XOMA Royalty acquires Generation Bio

XOMA Royalty agreed to acquire Generation Bio. Reported deal value: Undisclosed. Status: Pending. Sector: biotechnology. Target headquarters context: Cambridge, Massachusetts, United States.

This page summarizes publicly available information about the transaction as of 2026-02-09. Figures and status may change as filings and press coverage update.

XOMA Royalty Corporation , a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company successfully completed its previously announced tender offer to acquire all outstanding shares of Generation Bio Co. common stock for a price per share of $4.29 13 in cash , plus one non-tradeable contingent value right and successfully completed its acquisition of Generation Bio